Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Somnomed Limited ( (AU:SOM) ).
Somnomed Limited has announced a change in the director’s interest, with Karen Borg acquiring 1,700,000 options, as approved at the company’s Annual General Meeting. This change reflects an increase in Borg’s stake in the company, potentially signaling confidence in the company’s future performance and strategic direction, which may impact stakeholders’ perceptions and the company’s market positioning.
The most recent analyst rating on (AU:SOM) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Somnomed Limited stock, see the AU:SOM Stock Forecast page.
More about Somnomed Limited
Somnomed Limited operates in the healthcare industry, focusing on providing oral appliance therapy for the treatment of sleep-related breathing disorders, including obstructive sleep apnea. The company is known for its innovative solutions that cater to both patients and healthcare professionals, aiming to improve sleep quality and overall health outcomes.
Average Trading Volume: 373,921
Technical Sentiment Signal: Buy
Current Market Cap: A$176.7M
For a thorough assessment of SOM stock, go to TipRanks’ Stock Analysis page.